{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T01:06:30Z","timestamp":1763168790216,"version":"3.45.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"crossref","award":["LKZ2023012"],"award-info":[{"award-number":["LKZ2023012"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhenjiang Gastrointestinal Tumor Clinical Medical Key Laboratory","award":["SS2023011"],"award-info":[{"award-number":["SS2023011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-025-00711-w","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:09:09Z","timestamp":1763136549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An overview of hepatitis B virus in gastric carcinogenesis: from clinical association to molecular mechanisms"],"prefix":"10.1186","volume":"20","author":[{"given":"Yu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"8","key":"711_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current Status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20(8):524\u201337. https:\/\/doi.org\/10.1038\/s41575-023-00760-9. Epub 20230406.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"711_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.livres.2024.05.004","volume":"8","author":"W Abdelhamed","year":"2024","unstructured":"Abdelhamed W, El-Kassas M, Hepatitis B. Virus as a risk factor for hepatocellular carcinoma: there is still much work to do. Liver Res. 2024;8(2):83\u201390. https:\/\/doi.org\/10.1016\/j.livres.2024.05.004. Epub 20240601.","journal-title":"Liver Res"},{"key":"711_CR3","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834. Epub 20240404.","DOI":"10.3322\/caac.21834"},{"key":"711_CR4","doi-asserted-by":"publisher","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, Global Cancer S. 2018: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2018;68(6):394\u2013424. Epub 20180912. https:\/\/doi.org\/10.3322\/caac.21492","DOI":"10.3322\/caac.21492"},{"issue":"11","key":"711_CR5","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/ijc.33130","volume":"147","author":"T Tian","year":"2020","unstructured":"Tian T, Song C, Jiang L, Dai J, Lin Y, Xu X, et al. Hepatitis B virus infection and the risk of cancer among the Chinese population. Int J Cancer. 2020;147(11):3075\u201384. https:\/\/doi.org\/10.1002\/ijc.33130. Epub 20200716.","journal-title":"Int J Cancer"},{"issue":"3","key":"711_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ijc.31643","volume":"144","author":"P Mahale","year":"2019","unstructured":"Mahale P, Engels EA, Koshiol J. Hepatitis B virus infection and the risk of cancer in the elderly Us population. Int J Cancer. 2019;144(3):431\u20139. https:\/\/doi.org\/10.1002\/ijc.31643. Epub 20181128.","journal-title":"Int J Cancer"},{"issue":"6","key":"711_CR7","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jhep.2017.07.011","volume":"67","author":"N Rajoriya","year":"2017","unstructured":"Rajoriya N, Combet C, Zoulim F, Janssen HLA. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach? J Hepatol. 2017;67(6):1281\u201397. https:\/\/doi.org\/10.1016\/j.jhep.2017.07.011. Epub 20170721.","journal-title":"J Hepatol"},{"key":"711_CR8","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.2147\/dddt.S480151","volume":"18","author":"S Li","year":"2024","unstructured":"Li S, Hao L, Deng J, Zhang J, Yu F, Ye F, et al. The culprit behind Hbv-Infected hepatocytes: Ntcp. Drug Des Devel Ther. 2024;18:4839\u201358. https:\/\/doi.org\/10.2147\/dddt.S480151. Epub 20241028.","journal-title":"Drug Des Devel Ther"},{"key":"711_CR9","doi-asserted-by":"publisher","unstructured":"Boonstra A, Sari G. Hbv Cccdna: The Molecular Reservoir of Hepatitis B Persistence and Challenges to Achieve Viral Eradication. Biomolecules 2025; 15(1). Epub 20250104. https:\/\/doi.org\/10.3390\/biom15010062","DOI":"10.3390\/biom15010062"},{"key":"711_CR10","doi-asserted-by":"publisher","unstructured":"Tsukuda S, Watashi K, Hepatitis B. Virus biology and life cycle. Antiviral Res. 2020;182:104925. Epub 20200828. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104925","DOI":"10.1016\/j.antiviral.2020.104925"},{"key":"711_CR11","doi-asserted-by":"publisher","unstructured":"Mahmood F, Xu R, Awan MUN, Song Y, Han Q, Xia X, et al. Hbv Vaccines: Advances and Development. Vaccines (Basel). 2023;11(12). Epub 20231218. https:\/\/doi.org\/10.3390\/vaccines11121862","DOI":"10.3390\/vaccines11121862"},{"issue":"7903","key":"711_CR12","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/d41586-022-00811-2","volume":"603","author":"H Brody","year":"2022","unstructured":"Brody H, Hepatitis B. Nature. 2022;603(7903):S45. https:\/\/doi.org\/10.1038\/d41586-022-00811-2.","journal-title":"Nature"},{"issue":"2","key":"711_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s42770-023-00970-y","volume":"54","author":"S Boora","year":"2023","unstructured":"Boora S, Sharma V, Kaushik S, Bhupatiraju AV, Singh S, Kaushik S, Hepatitis B, Virus-Induced. Hepatocellular carcinoma: A persistent global problem. Braz J Microbiol. 2023;54(2):679\u201389. https:\/\/doi.org\/10.1007\/s42770-023-00970-y. Epub 20230414.","journal-title":"Braz J Microbiol"},{"key":"711_CR14","doi-asserted-by":"publisher","unstructured":"Yan R, Sun M, Yang H, Du S, Sun L, Mao Y. 2024 Latest Report on Hepatitis B Virus Epidemiology in China: Current Status, Changing Trajectory, and Challenges. Hepatobiliary Surg Nutr 2025;14(1):66\u201377. Epub 20250117. https:\/\/doi.org\/10.21037\/hbsn-2024-754","DOI":"10.21037\/hbsn-2024-754"},{"issue":"2","key":"711_CR15","first-page":"123","volume":"9","author":"MR Kappus","year":"2013","unstructured":"Kappus MR, Sterling RK. Extrahepatic manifestations of acute hepatitis B virus infection. Gastroenterol Hepatol (N Y). 2013;9(2):123\u20136.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"711_CR16","doi-asserted-by":"publisher","unstructured":"Songtanin B, Chaisrimaneepan N, Mend\u00f3za R, Nugent K. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections. Viruses 2024;16(4). Epub 20240416. https:\/\/doi.org\/10.3390\/v16040618","DOI":"10.3390\/v16040618"},{"key":"711_CR17","doi-asserted-by":"publisher","unstructured":"Mazzaro C, Adinolfi LE, Pozzato G, Nevola R, Zanier A, Serraino D et al. Extrahepatic Manifestations of Chronic Hbv Infection and the Role of Antiviral Therapy. J Clin Med 2022;11(21). Epub 20221023. https:\/\/doi.org\/10.3390\/jcm11216247","DOI":"10.3390\/jcm11216247"},{"issue":"1","key":"711_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.rdc.2009.03.006","volume":"35","author":"P Cacoub","year":"2009","unstructured":"Cacoub P, Terrier B. Hepatitis B-Related autoimmune manifestations. Rheum Dis Clin North Am. 2009;35(1):125\u201337. https:\/\/doi.org\/10.1016\/j.rdc.2009.03.006.","journal-title":"Rheum Dis Clin North Am"},{"key":"711_CR19","doi-asserted-by":"publisher","unstructured":"[the Guidelines of Prevention and Treatment for Chronic, Hepatitis B. (2019 Version)]. Zhonghua Gan Zang Bing Za Zhi 2019;27(12):938\u2009\u2013\u200961. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2019.12.007","DOI":"10.3760\/cma.j.issn.1007-3418.2019.12.007"},{"issue":"6","key":"711_CR20","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.14218\/jcth.2023.00320","volume":"11","author":"H You","year":"2023","unstructured":"You H, Wang F, Li T, Xu X, Sun Y, Nan Y, et al. Guidelines for the prevention and treatment of chronic hepatitis B (Version 2022). J Clin Transl Hepatol. 2023;11(6):1425\u201342. https:\/\/doi.org\/10.14218\/jcth.2023.00320. Epub 20230815.","journal-title":"J Clin Transl Hepatol"},{"key":"711_CR21","doi-asserted-by":"publisher","unstructured":"Li D, Hamadalnil Y, Tu T, Hepatitis B, Viral Protein. Hbx: Roles in Viral Replication and Hepatocarcinogenesis. Viruses 2024;16(9). Epub 20240826. https:\/\/doi.org\/10.3390\/v16091361","DOI":"10.3390\/v16091361"},{"issue":"2","key":"711_CR22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/jvi.02440-14","volume":"89","author":"S Rawat","year":"2015","unstructured":"Rawat S, Bouchard MJ. The hepatitis B virus (Hbv) Hbx protein activates Akt to simultaneously regulate Hbv replication and hepatocyte survival. J Virol. 2015;89(2):999\u20131012. https:\/\/doi.org\/10.1128\/jvi.02440-14. Epub 20141029.","journal-title":"J Virol"},{"key":"711_CR23","doi-asserted-by":"publisher","unstructured":"Rajput P, Shukla SK, Kumar V. The Hbx Oncoprotein of Hepatitis B Virus Potentiates Cell Transformation by Inducing C-Myc-Dependent Expression of the Rna Polymerase I Transcription Factor Ubf. Virol J 2015;12:62. Epub 20150414. https:\/\/doi.org\/10.1186\/s12985-015-0293-5","DOI":"10.1186\/s12985-015-0293-5"},{"issue":"1","key":"711_CR24","doi-asserted-by":"publisher","first-page":"e16202","DOI":"10.1111\/liv.16202","volume":"45","author":"T Tu","year":"2025","unstructured":"Tu T, McQuaid TJ, Jacobson IM. Hbv-Induced carcinogenesis: Mechanisms, correlation with viral Suppression, and implications for treatment. Liver Int. 2025;45(1):e16202. https:\/\/doi.org\/10.1111\/liv.16202.","journal-title":"Liver Int"},{"key":"711_CR25","doi-asserted-by":"publisher","unstructured":"Feitelson MA, Arzumanyan A, Spector I, Medhat A. Hepatitis B X (Hbx) as a Component of a Functional Cure for Chronic Hepatitis B. Biomedicines 2022;10(9). Epub 20220907. https:\/\/doi.org\/10.3390\/biomedicines10092210","DOI":"10.3390\/biomedicines10092210"},{"issue":"4","key":"711_CR26","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jhep.2009.10.033","volume":"52","author":"C Neuveut","year":"2010","unstructured":"Neuveut C, Wei Y, Buendia MA. Mechanisms of Hbv-Related hepatocarcinogenesis. J Hepatol. 2010;52(4):594\u2013604. https:\/\/doi.org\/10.1016\/j.jhep.2009.10.033. Epub 20100107.","journal-title":"J Hepatol"},{"issue":"6","key":"711_CR27","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1002\/ctm2.1313","volume":"13","author":"H Zou","year":"2023","unstructured":"Zou H, Wang Y, Lu L, Yao K, Wang C, Ma K, et al. Hbv-Integrated local genomic alterations reveal multicentric independent occurrences of multifocal Hcc. Clin Transl Med. 2023;13(6):e1313. https:\/\/doi.org\/10.1002\/ctm2.1313.","journal-title":"Clin Transl Med"},{"issue":"8","key":"711_CR28","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1002\/ijc.33027","volume":"147","author":"M Li","year":"2020","unstructured":"Li M, Shen Y, Chen Y, Gao H, Zhou J, Wang Q, et al. Characterization of hepatitis B virus infection and viral DNA integration in Non-Hodgkin lymphoma. Int J Cancer. 2020;147(8):2199\u2013209. https:\/\/doi.org\/10.1002\/ijc.33027. Epub 20200509.","journal-title":"Int J Cancer"},{"issue":"1","key":"711_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/hepr.13580","volume":"51","author":"M Li","year":"2021","unstructured":"Li M, Du M, Cong H, Gu Y, Fang Y, Li J, et al. Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma. Hepatol Res. 2021;51(1):102\u201315. https:\/\/doi.org\/10.1111\/hepr.13580. Epub 20201106.","journal-title":"Hepatol Res"},{"issue":"6","key":"711_CR30","doi-asserted-by":"publisher","first-page":"e195718","DOI":"10.1001\/jamanetworkopen.2019.5718","volume":"2","author":"C Song","year":"2019","unstructured":"Song C, Lv J, Liu Y, Chen JG, Ge Z, Zhu J, et al. Associations between hepatitis B virus infection and risk of all cancer types. JAMA Netw Open. 2019;2(6):e195718. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.5718. Epub 20190605.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"711_CR31","doi-asserted-by":"publisher","first-page":"e1601","DOI":"10.1002\/ctm2.1601","volume":"14","author":"M Li","year":"2024","unstructured":"Li M, Wu S, Niu J, Luo H, Chen W, Cao L, et al. Identification of hepatitis B virus infection and integration and its oncogenic role in gastric cancer. Clin Transl Med. 2024;14(3):e1601. https:\/\/doi.org\/10.1002\/ctm2.1601.","journal-title":"Clin Transl Med"},{"issue":"1","key":"711_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/s2468-1253(19)30328-0","volume":"5","author":"The Global","year":"2020","unstructured":"The Global. Regional, and National burden of stomach cancer in 195 Countries, 1990\u20132017: A systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):42\u201354. https:\/\/doi.org\/10.1016\/s2468-1253(19)30328-0. Epub 20191021.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"711_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.6004\/jnccn.2025.0022","volume":"23","author":"JA Ajani","year":"2025","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Corvera CU, Das P, Enzinger PC, et al. Gastric Cancer, version 2.2025, Nccn clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2025;23(5):169\u201391. https:\/\/doi.org\/10.6004\/jnccn.2025.0022.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"711_CR34","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold M, Park JY, Camargo MC, Lunet N, Forman D, Soerjomataram I. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 2020;69(5):823\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2019-320234. Epub 20200130.","journal-title":"Gut"},{"issue":"9","key":"711_CR35","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69(9):1564\u201371. https:\/\/doi.org\/10.1136\/gutjnl-2020-321600. Epub 20200630.","journal-title":"Gut"},{"issue":"6","key":"711_CR36","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/jnci\/djx262","volume":"110","author":"WF Anderson","year":"2018","unstructured":"Anderson WF, Rabkin CS, Turner N, Fraumeni JF Jr., Rosenberg PS, Camargo MC. The changing face of noncardia gastric cancer incidence among Us Non-Hispanic Whites. J Natl Cancer Inst. 2018;110(6):608\u201315. https:\/\/doi.org\/10.1093\/jnci\/djx262.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"711_CR37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: Esmo clinical practice guideline for Diagnosis, treatment and Follow-Up. Ann Oncol. 2022;33(10):1005\u201320. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.004. Epub 20220729.","journal-title":"Ann Oncol"},{"key":"711_CR38","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics. 2020: Globocan Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71(3):209\u2009\u2013\u200949. Epub 20210204. https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"issue":"2","key":"711_CR39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000350876","volume":"30","author":"HI Grabsch","year":"2013","unstructured":"Grabsch HI, Tan P. Gastric cancer pathology and underlying molecular mechanisms. Dig Surg. 2013;30(2):150\u20138. https:\/\/doi.org\/10.1159\/000350876. Epub 20130718.","journal-title":"Dig Surg"},{"issue":"7517","key":"711_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Comprehensive Molecular Characterization of Gastric Adenocarcinoma","year":"2014","unstructured":"Comprehensive Molecular Characterization of Gastric Adenocarcinoma. Nature. 2014;513(7517):202\u20139. https:\/\/doi.org\/10.1038\/nature13480. Epub 20140723.","journal-title":"Nature"},{"key":"711_CR41","doi-asserted-by":"publisher","first-page":"583463","DOI":"10.3389\/fonc.2020.583463","volume":"10","author":"K Sun","year":"2020","unstructured":"Sun K, Jia K, Lv H, Wang SQ, Wu Y, Lei H, et al. Ebv-Positive gastric cancer: current knowledge and future perspectives. Front Oncol. 2020;10:583463. https:\/\/doi.org\/10.3389\/fonc.2020.583463. Epub 20201214.","journal-title":"Front Oncol"},{"key":"711_CR42","doi-asserted-by":"publisher","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int J Mol Sci 2020;21(11). Epub 20200604. https:\/\/doi.org\/10.3390\/ijms21114012","DOI":"10.3390\/ijms21114012"},{"issue":"2","key":"711_CR43","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and Meta-Analysis. Gastroenterology. 2017;153(2):420\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.022. Epub 20170427.","journal-title":"Gastroenterology"},{"issue":"4","key":"711_CR44","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1097\/ms9.0000000000001802","volume":"86","author":"Y Gu","year":"2024","unstructured":"Gu Y, Xu Y, Wang P, Zhao Y, Wan C. Research progress on molecular mechanism of pyroptosis caused by Helicobacter pylori in gastric cancer. Ann Med Surg (Lond). 2024;86(4):2016\u201322. https:\/\/doi.org\/10.1097\/ms9.0000000000001802. Epub 20240215.","journal-title":"Ann Med Surg (Lond)"},{"issue":"6","key":"711_CR45","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.14309\/ctg.0000000000000714","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Hahn AI, Laszkowska M, Jiang F, Zauber AG, Leung WK. Clinicopathological characteristics and risk factors of Young-Onset gastric carcinoma: A systematic review and Meta-Analysis. Clin Transl Gastroenterol. 2024;15(6):e1. https:\/\/doi.org\/10.14309\/ctg.0000000000000714. Epub 20240601.","journal-title":"Clin Transl Gastroenterol"},{"key":"711_CR46","doi-asserted-by":"publisher","unstructured":"Wroblewski LE, Peek RM. Jr. Helicobacter Pylori in Gastric Carcinogenesis: Mechanisms. Gastroenterol Clin North Am 2013;42(2):285\u2009\u2013\u200998. Epub 20130306. https:\/\/doi.org\/10.1016\/j.gtc.2013.01.006","DOI":"10.1016\/j.gtc.2013.01.006"},{"issue":"22","key":"711_CR47","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.3748\/wjg.v23.i22.3964","volume":"23","author":"M Chmiela","year":"2017","unstructured":"Chmiela M, Gonciarz W. Molecular mimicry in Helicobacter pylori infections. World J Gastroenterol. 2017;23(22):3964\u201377. https:\/\/doi.org\/10.3748\/wjg.v23.i22.3964.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"711_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s2352-4642(21)00400-4","volume":"6","author":"C Yuan","year":"2022","unstructured":"Yuan C, Adeloye D, Luk TT, Huang L, He Y, Xu Y, et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6(3):185\u201394. https:\/\/doi.org\/10.1016\/s2352-4642(21)00400-4. Epub 20220125.","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"711_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/1319-3767.54743","volume":"15","author":"BA Salih","year":"2009","unstructured":"Salih BA. Helicobacter pylori infection in developing countries: the burden for how long? Saudi J Gastroenterol. 2009;15(3):201\u20137. https:\/\/doi.org\/10.4103\/1319-3767.54743.","journal-title":"Saudi J Gastroenterol"},{"issue":"3","key":"711_CR50","first-page":"133","volume":"73","author":"JG Smith","year":"2009","unstructured":"Smith JG, Li W, Rosson RS. Prevalence, clinical and endoscopic predictors of Helicobacter pylori infection in an urban population. Conn Med. 2009;73(3):133\u20137.","journal-title":"Conn Med"},{"issue":"3","key":"711_CR51","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s10120-024-01475-9","volume":"27","author":"JW Mok","year":"2024","unstructured":"Mok JW, Oh YH, Magge D, Padmanabhan S. Racial disparities of gastric cancer in the USA: an overview of Epidemiology, global screening Guidelines, and targeted screening in a heterogeneous population. Gastric Cancer. 2024;27(3):426\u201338. https:\/\/doi.org\/10.1007\/s10120-024-01475-9. Epub 20240304.","journal-title":"Gastric Cancer"},{"issue":"1","key":"711_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","volume":"18","author":"Y Duan","year":"2025","unstructured":"Duan Y, Xu Y, Dou Y, Xu D. Helicobacter pylori and gastric cancer: mechanisms and new perspectives. J Hematol Oncol. 2025;18(1):10. https:\/\/doi.org\/10.1186\/s13045-024-01654-2. Epub 20250123.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"711_CR53","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12885-020-07013-x","volume":"20","author":"A Tavakoli","year":"2020","unstructured":"Tavakoli A, Monavari SH, Solaymani Mohammadi F, Kiani SJ, Armat S, Farahmand M. Association between Epstein-Barr virus infection and gastric cancer: A systematic review and Meta-Analysis. BMC Cancer. 2020;20(1):493. https:\/\/doi.org\/10.1186\/s12885-020-07013-x. Epub 20200601.","journal-title":"BMC Cancer"},{"issue":"R1","key":"711_CR54","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89\u201398. https:\/\/doi.org\/10.1093\/hmg\/ddu328. Epub 20140704.","journal-title":"Hum Mol Genet"},{"issue":"14","key":"711_CR55","doi-asserted-by":"publisher","first-page":"e37645","DOI":"10.1097\/md.0000000000037645","volume":"103","author":"H Cai","year":"2024","unstructured":"Cai H, Huang T, Zheng B, Zhu X, Zhou L, Wu J, et al. Exploring the evolutionary mechanism of hepatitis B and gastric cancer based on Mendelian randomization combined with bioinformatics analysis. Med (Baltim). 2024;103(14):e37645. https:\/\/doi.org\/10.1097\/md.0000000000037645.","journal-title":"Med (Baltim)"},{"issue":"1","key":"711_CR56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jmv.25584","volume":"92","author":"H Cui","year":"2020","unstructured":"Cui H, Jin Y, Chen F, Ni H, Hu C, Xu Y, et al. Clinicopathological evidence of hepatitis B virus infection in the development of gastric adenocarcinoma. J Med Virol. 2020;92(1):71\u20137. https:\/\/doi.org\/10.1002\/jmv.25584. Epub 20190910.","journal-title":"J Med Virol"},{"issue":"7","key":"711_CR57","doi-asserted-by":"publisher","first-page":"e00201","DOI":"10.14309\/ctg.0000000000000201","volume":"11","author":"H Wang","year":"2020","unstructured":"Wang H, Chen XL, Liu K, Bai D, Zhang WH, Chen XZ, et al. Associations between gastric cancer risk and virus infection other than Epstein-Barr virus: A systematic review and Meta-Analysis based on epidemiological studies. Clin Transl Gastroenterol. 2020;11(7):e00201. https:\/\/doi.org\/10.14309\/ctg.0000000000000201.","journal-title":"Clin Transl Gastroenterol"},{"key":"711_CR58","doi-asserted-by":"publisher","first-page":"703558","DOI":"10.3389\/fonc.2021.703558","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang Y, Jiang Z, Wu W, Ruan L, Yu C, Xi Y, et al. Chronic hepatitis virus infection are associated with high risk of gastric cancer: A systematic review and cumulative analysis. Front Oncol. 2021;11:703558. https:\/\/doi.org\/10.3389\/fonc.2021.703558. Epub 20210708.","journal-title":"Front Oncol"},{"issue":"2","key":"711_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.imj.2023.04.003","volume":"2","author":"R Yu","year":"2023","unstructured":"Yu R, Huang J, Peng H, Yin S, Xie W, Ren S, et al. Association between hepatitis B virus and gastric cancer: A systematic review and Meta-Analysis. Infect Med (Beijing). 2023;2(2):67\u201373. https:\/\/doi.org\/10.1016\/j.imj.2023.04.003. Epub 20230423.","journal-title":"Infect Med (Beijing)"},{"issue":"7","key":"711_CR60","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.31557\/apjcp.2019.20.7.2177","volume":"20","author":"M Baghbanian","year":"2019","unstructured":"Baghbanian M, Hoseini Mousa SA, Doosti M, Moghimi M. Association between gastric pathology and hepatitis B virus infection in patients with or without Helicobacter pylori. Asian Pac J Cancer Prev. 2019;20(7):2177\u201380. https:\/\/doi.org\/10.31557\/apjcp.2019.20.7.2177. Epub 20190701.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"711_CR61","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/ijc.33891","volume":"150","author":"T Liu","year":"2022","unstructured":"Liu T, Song C, Zhang Y, Siyin ST, Zhang Q, Song M, et al. Hepatitis B virus infection and the risk of Gastrointestinal cancers among Chinese population: A prospective cohort study. Int J Cancer. 2022;150(6):1018\u201328. https:\/\/doi.org\/10.1002\/ijc.33891. Epub 20211214.","journal-title":"Int J Cancer"},{"issue":"9","key":"711_CR62","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/jvh.13304","volume":"27","author":"CY Hong","year":"2020","unstructured":"Hong CY, Sinn DH, Kang D, Paik SW, Guallar E, Cho J, et al. Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study. J Viral Hepat. 2020;27(9):896\u2013903. https:\/\/doi.org\/10.1111\/jvh.13304. Epub 20200518.","journal-title":"J Viral Hepat"},{"issue":"7","key":"711_CR63","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/bjc.2014.406","volume":"112","author":"XL Wei","year":"2015","unstructured":"Wei XL, Qiu MZ, Jin Y, Huang YX, Wang RY, Chen WW, et al. Hepatitis B virus infection is associated with gastric cancer in china: an endemic area of both diseases. Br J Cancer. 2015;112(7):1283\u201390. https:\/\/doi.org\/10.1038\/bjc.2014.406. Epub 20150331.","journal-title":"Br J Cancer"},{"issue":"11","key":"711_CR64","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1002\/cam4.3901","volume":"10","author":"H Wang","year":"2021","unstructured":"Wang H, Chen XZ, Chen XL, Zhang WH, Liu K, Wang YJ, et al. Associations between hepatitis B virus exposure and the risk of extrahepatic digestive system cancers: A Hospital-Based, Case-Control study (Siges). Cancer Med. 2021;10(11):3741\u201355. https:\/\/doi.org\/10.1002\/cam4.3901. Epub 20210502.","journal-title":"Cancer Med"},{"key":"711_CR65","doi-asserted-by":"publisher","first-page":"894836","DOI":"10.3389\/fcimb.2022.894836","volume":"12","author":"M Li","year":"2022","unstructured":"Li M, Wu S, Luo H, Niu J, Yan Y, Fang Y, et al. Serological and molecular characterization of hepatitis B virus infection in gastric cancer. Front Cell Infect Microbiol. 2022;12:894836. https:\/\/doi.org\/10.3389\/fcimb.2022.894836. Epub 20220503.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"711_CR66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13027-025-00648-0","volume":"20","author":"D Chen","year":"2025","unstructured":"Chen D, Yu R, Cai Y, Zhang H, Jiang Y, Wu Y, et al. Additive interaction between hepatitis B virus infection and tobacco smoking on the risk of gastric cancer in a Chinese population. Infect Agent Cancer. 2025;20(1):19. https:\/\/doi.org\/10.1186\/s13027-025-00648-0. Epub 20250320.","journal-title":"Infect Agent Cancer"},{"key":"711_CR67","doi-asserted-by":"publisher","unstructured":"Kamiza AB, Fatumo S, Singini MG, Yeh CC, Chikowore T, Hepatitis B. Infection Is Causally Associated with Extrahepatic Cancers: A Mendelian Randomization Study. EBio Medicine 2022;79:104003. Epub 20220418. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104003","DOI":"10.1016\/j.ebiom.2022.104003"},{"issue":"1 Suppl","key":"711_CR68","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J. Mechanisms of Hbv-Induced hepatocellular carcinoma. J Hepatol. 2016;64(1 Suppl):S84\u2013101. https:\/\/doi.org\/10.1016\/j.jhep.2016.02.021.","journal-title":"J Hepatol"},{"issue":"4","key":"711_CR69","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jcmgh.2023.01.001","volume":"15","author":"SH Yeh","year":"2023","unstructured":"Yeh SH, Li CL, Lin YY, Ho MC, Wang YC, Tseng ST, et al. Hepatitis B virus DNA integration drives carcinogenesis and provides a new biomarker for Hbv-Related Hcc. Cell Mol Gastroenterol Hepatol. 2023;15(4):921\u20139. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.01.001. Epub 20230120.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"711_CR70","doi-asserted-by":"publisher","unstructured":"Lin SY, Zhang A, Lian J, Wang J, Chang TT, Lin YJ et al. Recurrent Hbv Integration Targets as Potential Drivers in Hepatocellular Carcinoma. Cells 2021;10(6). Epub 20210523. https:\/\/doi.org\/10.3390\/cells10061294","DOI":"10.3390\/cells10061294"},{"issue":"1","key":"711_CR71","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40364-024-00611-y","volume":"12","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chen H, Liu H, Tang H. The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy. Biomark Res. 2024;12(1):84. https:\/\/doi.org\/10.1186\/s40364-024-00611-y. Epub 20240815.","journal-title":"Biomark Res"},{"issue":"1","key":"711_CR72","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ijc.30719","volume":"141","author":"XL Wei","year":"2017","unstructured":"Wei XL, Luo HY, Li CF, Jin Y, Zeng ZL, Ju HQ, et al. Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers. Int J Cancer. 2017;141(1):152\u20139. https:\/\/doi.org\/10.1002\/ijc.30719. Epub 20170424.","journal-title":"Int J Cancer"},{"key":"711_CR73","doi-asserted-by":"publisher","unstructured":"Sivasudhan E, Blake N, Lu Z, Meng J, Rong R, Hepatitis B. Viral Protein Hbx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review. Cells 2022;11(4). Epub 20220221. https:\/\/doi.org\/10.3390\/cells11040741","DOI":"10.3390\/cells11040741"},{"issue":"47","key":"711_CR74","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.1073\/pnas.0908365106","volume":"106","author":"L Belloni","year":"2009","unstructured":"Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, et al. Nuclear Hbx binds the Hbv minichromosome and modifies the epigenetic regulation of Cccdna function. Proc Natl Acad Sci U S A. 2009;106(47):19975\u20139. https:\/\/doi.org\/10.1073\/pnas.0908365106. Epub 20091111.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"711_CR75","doi-asserted-by":"publisher","unstructured":"Villanueva RA, Loyola A. The Intrinsically Disordered Region of Hbx and Virus-Host Interactions: Uncovering New Therapeutic Approaches for Hbv and Cancer. Int J Mol Sci 2025;26(8). Epub 20250410. https:\/\/doi.org\/10.3390\/ijms26083552","DOI":"10.3390\/ijms26083552"},{"issue":"8","key":"711_CR76","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41388-019-1107-9","volume":"39","author":"KS Dong","year":"2020","unstructured":"Dong KS, Chen Y, Yang G, Liao ZB, Zhang HW, Liang HF, et al. Tgf-\u03921 accelerates the hepatitis B virus X-Induced malignant transformation of hepatic progenitor cells by upregulating Mir-199a-3p. Oncogene. 2020;39(8):1807\u201320. https:\/\/doi.org\/10.1038\/s41388-019-1107-9. Epub 20191118.","journal-title":"Oncogene"},{"issue":"3","key":"711_CR77","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1582-4934.2008.00622.x","volume":"14","author":"R Du","year":"2010","unstructured":"Du R, Xia L, Sun S, Lian Z, Zou X, Gao J, et al. Urg11 promotes gastric cancer growth and invasion by activation of Beta-Catenin signalling pathway. J Cell Mol Med. 2010;14(3):621\u201335. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00622.x. Epub 20081224.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"711_CR78","doi-asserted-by":"publisher","first-page":"2373276","DOI":"10.1080\/0886022x.2024.2373276","volume":"46","author":"L Bian","year":"2024","unstructured":"Bian L, Niu Y, Yuan W, Du H, Yang Y. Hbx promotes glomerular Podocyte-Induced immune cell responses. Ren Fail. 2024;46(2):2373276. https:\/\/doi.org\/10.1080\/0886022x.2024.2373276. Epub 20240705.","journal-title":"Ren Fail"},{"issue":"9","key":"711_CR79","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.7150\/jca.24384","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang H, Pan S, Hu T, Shen J, Zheng H, et al. Capable infection of hepatitis B virus in diffuse large B-Cell lymphoma. J Cancer. 2018;9(9):1575\u201381. https:\/\/doi.org\/10.7150\/jca.24384. Epub 20180412.","journal-title":"J Cancer"},{"issue":"5","key":"711_CR80","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3892\/or.2012.2011","volume":"28","author":"PT Guo","year":"2012","unstructured":"Guo PT, Yang D, Sun Z, Xu HM, Hepatitis B, Virus X. Protein plays an important role in gastric ulcers. Oncol Rep. 2012;28(5):1653\u20138. https:\/\/doi.org\/10.3892\/or.2012.2011. Epub 20120903.","journal-title":"Oncol Rep"},{"issue":"8","key":"711_CR81","doi-asserted-by":"publisher","first-page":"Epub20210812","DOI":"10.3390\/life11080823","volume":"11","author":"A Klonou","year":"2021","unstructured":"Klonou A, Chlamydas S, Piperi C. Structure, activity and function of the Mll2 (Kmt2b) protein lysine methyltransferase. Life (Basel). 2021;11(8):Epub20210812. https:\/\/doi.org\/10.3390\/life11080823.","journal-title":"Life (Basel)"},{"issue":"1","key":"711_CR82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7150\/ijbs.72381","volume":"19","author":"D Zhao","year":"2023","unstructured":"Zhao D, Yuan H, Fang Y, Gao J, Li H, Li M, et al. Histone methyltransferase Kmt2b promotes metastasis and angiogenesis of cervical cancer by upregulating Egf expression. Int J Biol Sci. 2023;19(1):34\u201349. https:\/\/doi.org\/10.7150\/ijbs.72381. Epub 20230101.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"711_CR83","doi-asserted-by":"publisher","first-page":"101422","DOI":"10.1016\/j.jcmgh.2024.101422","volume":"19","author":"J Tsuchiya","year":"2025","unstructured":"Tsuchiya J, Miyoshi M, Kakinuma S, Kawai-Kitahata F, Kamiya A, Shimizu T, et al. Hepatitis B Virus-Kmt2b integration drives hepatic oncogenic processes in a human Gene-Edited induced pluripotent stem Cells-Derived model. Cell Mol Gastroenterol Hepatol. 2025;19(2):101422. https:\/\/doi.org\/10.1016\/j.jcmgh.2024.101422. Epub 20241016.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7471","key":"711_CR84","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502(7471):333\u20139. https:\/\/doi.org\/10.1038\/nature12634.","journal-title":"Nature"},{"issue":"1","key":"711_CR85","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12885-018-4159-2","volume":"18","author":"H Lu","year":"2018","unstructured":"Lu H, Yang S, Zhu H, Tong X, Xie F, Qin J, et al. Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma. BMC Cancer. 2018;18(1):251. https:\/\/doi.org\/10.1186\/s12885-018-4159-2. Epub 20180305.","journal-title":"BMC Cancer"},{"issue":"7","key":"711_CR86","first-page":"1540","volume":"7","author":"S Ge","year":"2017","unstructured":"Ge S, Li B, Li Y, Li Z, Liu Z, Chen Z, et al. Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted Next-Generation sequencing. Am J Cancer Res. 2017;7(7):1540\u201353. Epub 20170701.","journal-title":"Am J Cancer Res"},{"key":"711_CR87","doi-asserted-by":"publisher","unstructured":"He X, Yu M, Wang X, Chen J, Li X. Analysis of Threshold Change of Tumor Mutation Burden in Gastric Cancer. J Oncol 2021;2021:3374939. Epub 20210722. https:\/\/doi.org\/10.1155\/2021\/3374939","DOI":"10.1155\/2021\/3374939"},{"key":"711_CR88","doi-asserted-by":"publisher","first-page":"123523","DOI":"10.1016\/j.lfs.2025.123523","volume":"369","author":"K Wang","year":"2025","unstructured":"Wang K, Zhan F, Yang X, Jiao M, Wang P, Zhang H, et al. Kmt2d: A key emerging epigenetic regulator in head and neck diseases and tumors. Life Sci. 2025;369:123523. https:\/\/doi.org\/10.1016\/j.lfs.2025.123523. Epub 20250303.","journal-title":"Life Sci"},{"key":"711_CR89","doi-asserted-by":"publisher","unstructured":"Froimchuk E, Jang Y, Ge K. Histone H3 Lysine 4 Methyltransferase Kmt2d. Gene 2017;627:337\u2009\u2013\u200942. Epub 20170629. https:\/\/doi.org\/10.1016\/j.gene.2017.06.056","DOI":"10.1016\/j.gene.2017.06.056"},{"key":"711_CR90","doi-asserted-by":"publisher","first-page":"108924","DOI":"10.1016\/j.biopha.2019.108924","volume":"115","author":"P Sun","year":"2019","unstructured":"Sun P, Wu T, Sun X, Cui Z, Zhang H, Xia Q, et al. Kmt2d inhibits the growth and metastasis of bladder cancer cells by maintaining the tumor suppressor genes. Biomed Pharmacother. 2019;115:108924. https:\/\/doi.org\/10.1016\/j.biopha.2019.108924. Epub 20190514.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"711_CR91","doi-asserted-by":"publisher","first-page":"e23721","DOI":"10.1002\/jcla.23721","volume":"35","author":"Q Li","year":"2021","unstructured":"Li Q, Wu R, Wu F, Chen Q. Kmt2d promotes proliferation of gastric cancer cells: evidence from ctdna sequencing. J Clin Lab Anal. 2021;35(4):e23721. https:\/\/doi.org\/10.1002\/jcla.23721. Epub 20210401.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"711_CR92","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbrc.2018.08.143","volume":"504","author":"W Xiong","year":"2018","unstructured":"Xiong W, Deng Z, Tang Y, Deng Z, Li M. Downregulation of Kmt2d suppresses proliferation and induces apoptosis of gastric cancer. Biochem Biophys Res Commun. 2018;504(1):129\u201336. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.143. Epub 20180901.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"711_CR93","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/jgh.12078","volume":"28","author":"YL Shih","year":"2013","unstructured":"Shih YL, Hsieh CB, Yan MD, Tsao CM, Hsieh TY, Liu CH, et al. Frequent concomitant epigenetic Silencing of Sox1 and secreted Frizzled-Related proteins (Sfrps) in human hepatocellular carcinoma. J Gastroenterol Hepatol. 2013;28(3):551\u20139. https:\/\/doi.org\/10.1111\/jgh.12078.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"711_CR94","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12957-025-03790-6","volume":"23","author":"Y Hu","year":"2025","unstructured":"Hu Y, Cui M. Meta-Analysis of the diagnostic value of Sox1 methylation in different types of cervical cancer. World J Surg Oncol. 2025;23(1):147. https:\/\/doi.org\/10.1186\/s12957-025-03790-6. Epub 20250421.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"711_CR95","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10142-024-01517-6","volume":"25","author":"SA Jasim","year":"2025","unstructured":"Jasim SA, Farhan SH, Ahmad I, Hjazi A, Kumar A, Jawad MA, et al. A Cutting-Edge investigation of the multifaceted role of Sox family genes in cancer pathogenesis through the modulation of various signaling pathways. Funct Integr Genomics. 2025;25(1):6. https:\/\/doi.org\/10.1007\/s10142-024-01517-6. Epub 20250104.","journal-title":"Funct Integr Genomics"},{"key":"711_CR96","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12935-020-01395-5","volume":"20","author":"L Yin","year":"2020","unstructured":"Yin L, Liu T, Li C, Yan G, Li C, Zhang J, et al. The Mrtf-a\/Mir-155\/Sox1 pathway mediates gastric cancer migration and invasion. Cancer Cell Int. 2020;20:303. https:\/\/doi.org\/10.1186\/s12935-020-01395-5. Epub 20200711.","journal-title":"Cancer Cell Int"},{"key":"711_CR97","doi-asserted-by":"publisher","first-page":"100740","DOI":"10.1016\/j.diff.2023.100740","volume":"139","author":"M Biadun","year":"2024","unstructured":"Biadun M, Karelus R, Krowarsch D, Opalinski L, Zakrzewska M. Fgf12: biology and function. Differentiation. 2024;139:100740. https:\/\/doi.org\/10.1016\/j.diff.2023.100740. Epub 20231125.","journal-title":"Differentiation"},{"issue":"13","key":"711_CR98","doi-asserted-by":"publisher","first-page":"e34005","DOI":"10.1016\/j.heliyon.2024.e34005","volume":"10","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Chen H, Zhang W, Zhou H. Identification of cancer-Associated Fibroblast-Related Ectodysplasin-a as a novel indicator for prognosis and immune response in gastric cancer. Heliyon. 2024;10(13):e34005. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34005. Epub 20240702.","journal-title":"Heliyon"},{"issue":"10308","key":"711_CR99","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/s0140-6736(21)01374-x","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359\u201376. https:\/\/doi.org\/10.1016\/s0140-6736(21)01374-x. Epub 20210917.","journal-title":"Lancet"},{"issue":"2","key":"711_CR100","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/hep.26385","volume":"58","author":"MH Lee","year":"2013","unstructured":"Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, et al. Prediction models of Long-Term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. Hepatology. 2013;58(2):546\u201354. https:\/\/doi.org\/10.1002\/hep.26385.","journal-title":"Hepatology"},{"issue":"6","key":"711_CR101","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, et al. Global epidemiology of Cirrhosis - Aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388\u201398. https:\/\/doi.org\/10.1038\/s41575-023-00759-2. Epub 20230328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"711_CR102","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1017\/s0950268814000806","volume":"143","author":"A Ahmadi Vasmehjani","year":"2015","unstructured":"Ahmadi Vasmehjani A, Javeshghani D, Baharlou R, Shayestehpour M, Mousavinasab SD, Joharinia N, et al. Hepatitis a infection in patients with chronic viral liver disease: A Cross-Sectional study in Jahrom, Iran. Epidemiol Infect. 2015;143(3):534\u20139. https:\/\/doi.org\/10.1017\/s0950268814000806. Epub 20140417.","journal-title":"Epidemiol Infect"},{"issue":"3","key":"711_CR103","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00008469-200306000-00002","volume":"12","author":"A Zullo","year":"2003","unstructured":"Zullo A, Romiti A, Tomao S, Hassan C, Rinaldi V, Giustini M, et al. Gastric cancer prevalence in patients with liver cirrhosis. Eur J Cancer Prev. 2003;12(3):179\u201382. https:\/\/doi.org\/10.1097\/00008469-200306000-00002.","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"711_CR104","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cgh.2010.10.014","volume":"9","author":"E Kalaitzakis","year":"2011","unstructured":"Kalaitzakis E, Gunnarsdottir SA, Josefsson A, Bj\u00f6rnsson E. Increased risk for malignant neoplasms among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(2):168\u201374. https:\/\/doi.org\/10.1016\/j.cgh.2010.10.014. Epub 20101026.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"711_CR105","doi-asserted-by":"publisher","first-page":"451","DOI":"10.20524\/aog.2019.0399","volume":"32","author":"T Voulgaris","year":"2019","unstructured":"Voulgaris T, Karagiannakis D, Siakavellas S, Kalogera D, Angelopoulos T, Chloupi E, et al. High prevalence of asymptomatic peptic ulcers diagnosed during screening endoscopy in patients with cirrhosis. Ann Gastroenterol. 2019;32(5):451\u20136. https:\/\/doi.org\/10.20524\/aog.2019.0399. Epub 20190706.","journal-title":"Ann Gastroenterol"},{"key":"711_CR106","doi-asserted-by":"publisher","unstructured":"Paragomi P, Dabo B, Pelucchi C, Bonzi R, Bako AT, Sanusi NM, et al. The association between peptic ulcer disease and gastric cancer: results from the stomach cancer pooling (Stop) project consortium. Cancers (Basel). 2022;14(19). https:\/\/doi.org\/10.3390\/cancers14194905. Epub 20221007.","DOI":"10.3390\/cancers14194905"},{"key":"711_CR107","doi-asserted-by":"publisher","unstructured":"Jeng KS, Chang CF, Sheen IS, Jeng CJ, Wang CH. Upper Gastrointestinal cancer and liver cirrhosis. Cancers (Basel). 2022;14(9). https:\/\/doi.org\/10.3390\/cancers14092269. Epub 20220502.","DOI":"10.3390\/cancers14092269"},{"issue":"3","key":"711_CR108","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1023\/a:1005647115304","volume":"46","author":"A Zullo","year":"2001","unstructured":"Zullo A, Romiti A, Rinaldi V, Vecchione A, Hassan C, Winn S, et al. Gastric epithelial cell proliferation in patients with liver cirrhosis. Dig Dis Sci. 2001;46(3):550\u20134. https:\/\/doi.org\/10.1023\/a:1005647115304.","journal-title":"Dig Dis Sci"},{"issue":"12","key":"711_CR109","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/meg.0000000000000220","volume":"26","author":"H Feng","year":"2014","unstructured":"Feng H, Zhou X, Zhang G. Association between cirrhosis and Helicobacter pylori infection: A Meta-Analysis. Eur J Gastroenterol Hepatol. 2014;26(12):1309\u201319. https:\/\/doi.org\/10.1097\/meg.0000000000000220.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"711_CR110","doi-asserted-by":"publisher","unstructured":"Wu X, Yu J, Luo X, Lan Y. Association of Hepatitis B Virus Infection and Helicobacter Pylori Co-Infection with Gastric Disorders and Cancer. Am J Med Sci 2025. Epub 20250613. https:\/\/doi.org\/10.1016\/j.amjms.2025.06.009","DOI":"10.1016\/j.amjms.2025.06.009"},{"issue":"3","key":"711_CR111","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The Gut-Liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020;72(3):558\u201377. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.003. Epub 20191014.","journal-title":"J Hepatol"},{"issue":"11","key":"711_CR112","doi-asserted-by":"publisher","first-page":"e1980","DOI":"10.1038\/cddis.2015.322","volume":"6","author":"B Liu","year":"2015","unstructured":"Liu B, Fang M, He Z, Cui D, Jia S, Lin X, et al. Hepatitis B virus stimulates G6pd expression through Hbx-Mediated Nrf2 activation. Cell Death Dis. 2015;6(11):e1980. https:\/\/doi.org\/10.1038\/cddis.2015.322. Epub 20151119.","journal-title":"Cell Death Dis"},{"key":"711_CR113","doi-asserted-by":"publisher","unstructured":"Yan Y, Wei Z, Zheng M, Lu M, Wang X. Hbv and Host Metabolic Crosstalk: Reprogramming Pathways for Viral Replication and Pathogenesis. Virol Sin 2025. Epub 20250927. https:\/\/doi.org\/10.1016\/j.virs.2025.09.008","DOI":"10.1016\/j.virs.2025.09.008"},{"issue":"3","key":"711_CR114","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1478-3231.2010.02423.x","volume":"31","author":"I Bar-Yishay","year":"2011","unstructured":"Bar-Yishay I, Shaul Y, Shlomai A. Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int. 2011;31(3):282\u201390. https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02423.x. Epub 20110111.","journal-title":"Liver Int"},{"issue":"3","key":"711_CR115","doi-asserted-by":"publisher","first-page":"e1008866","DOI":"10.1371\/journal.ppat.1008866","volume":"17","author":"YH Wu","year":"2021","unstructured":"Wu YH, Yang Y, Chen CH, Hsiao CJ, Li TN, Liao KJ, et al. Aerobic Glycolysis supports hepatitis B virus protein synthesis through interaction between viral surface antigen and pyruvate kinase isoform M2. PLoS Pathog. 2021;17(3):e1008866. https:\/\/doi.org\/10.1371\/journal.ppat.1008866. Epub 20210315.","journal-title":"PLoS Pathog"},{"issue":"1","key":"711_CR116","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13046-022-02531-x","volume":"41","author":"L Chen","year":"2022","unstructured":"Chen L, Lin X, Lei Y, Xu X, Zhou Q, Chen Y, et al. Aerobic Glycolysis enhances Hbx-Initiated hepatocellular carcinogenesis via Nf-\u039abp65\/Hk2 signalling. J Exp Clin Cancer Res. 2022;41(1):329. https:\/\/doi.org\/10.1186\/s13046-022-02531-x. Epub 20221121.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"711_CR117","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12964-024-01619-5","volume":"22","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Zhao Y, Ning Z, Deng Y, Li B, Sun Y, et al. Metabolic Self-Feeding in Hbv-Associated hepatocarcinoma centered on feedback between circulation lipids and the cellular Mapk\/Mtor axis. Cell Commun Signal. 2024;22(1):280. https:\/\/doi.org\/10.1186\/s12964-024-01619-5. Epub 20240521.","journal-title":"Cell Commun Signal"},{"key":"711_CR118","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.2147\/ott.S243250","volume":"13","author":"L Qiu","year":"2020","unstructured":"Qiu L, Lu F, Zhang L, Wang G, Geng R, Miao Y. Hbxip regulates gastric cancer glucose metabolism and malignancy through Pi3k\/Akt and P53 signaling. Onco Targets Ther. 2020;13:3359\u201374. https:\/\/doi.org\/10.2147\/ott.S243250. Epub 20200421.","journal-title":"Onco Targets Ther"},{"key":"711_CR119","doi-asserted-by":"publisher","unstructured":"Maiorino L, Da\u00dfler-Plenker J, Sun L, Egeblad M. Innate Immunity and Cancer Pathophysiology. Annu Rev Pathol 2022;17:425\u2009\u2013\u200957. Epub 20211117. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-032221-115501","DOI":"10.1146\/annurev-pathmechdis-032221-115501"},{"issue":"1","key":"711_CR120","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-0038-1676806","volume":"39","author":"YM Yang","year":"2019","unstructured":"Yang YM, Kim SY, Seki E. Inflammation and liver cancer: molecular mechanisms and therapeutic targets. Semin Liver Dis. 2019;39(1):26\u201342. https:\/\/doi.org\/10.1055\/s-0038-1676806. Epub 20190117.","journal-title":"Semin Liver Dis"},{"key":"711_CR121","doi-asserted-by":"publisher","unstructured":"Jaroenlapnopparat A, Bhatia K, Coban S. Inflammation and Gastric Cancer. Diseases 2022;10(3). Epub 20220622. https:\/\/doi.org\/10.3390\/diseases10030035","DOI":"10.3390\/diseases10030035"},{"key":"711_CR122","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-3-030-15138-6_13","volume":"421","author":"MB Piazuelo","year":"2019","unstructured":"Piazuelo MB, Riechelmann RP, Wilson KT, Algood HMS. Resolution of gastric Cancer-Promoting inflammation: A novel strategy for Anti-Cancer therapy. Curr Top Microbiol Immunol. 2019;421:319\u201359. https:\/\/doi.org\/10.1007\/978-3-030-15138-6_13.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"4","key":"711_CR123","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.Cd-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 2021;11(4):933\u201359. https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-1808.","journal-title":"Cancer Discov"},{"issue":"3","key":"711_CR124","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/nsr\/nwu038","volume":"1","author":"P Yang","year":"2014","unstructured":"Yang P, Markowitz GJ, Wang XF. The hepatitis B Virus-Associated tumor microenvironment in hepatocellular carcinoma. Natl Sci Rev. 2014;1(3):396\u2013412. https:\/\/doi.org\/10.1093\/nsr\/nwu038.","journal-title":"Natl Sci Rev"},{"key":"711_CR125","doi-asserted-by":"publisher","unstructured":"Jin X, Yan ZH, Lu L, Lu S, Zhang G, Lin W. Peripheral Immune Cells Exhaustion and Functional Impairment in Patients with Chronic Hepatitis B. Front Med (Lausanne) 2021;8:759292. Epub 20211026. https:\/\/doi.org\/10.3389\/fmed.2021.759292","DOI":"10.3389\/fmed.2021.759292"},{"issue":"7","key":"711_CR126","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3748\/wjg.v20.i7.1667","volume":"20","author":"HW Chung","year":"2014","unstructured":"Chung HW, Lim JB. Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. World J Gastroenterol. 2014;20(7):1667\u201380. https:\/\/doi.org\/10.3748\/wjg.v20.i7.1667.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"711_CR127","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12935-023-02902-0","volume":"23","author":"HE Marei","year":"2023","unstructured":"Marei HE, Hasan A, Pozzoli G, Cenciarelli C. Cancer immunotherapy with immune checkpoint inhibitors (Icis): Potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired. Cancer Cell Int. 2023;23(1):64. https:\/\/doi.org\/10.1186\/s12935-023-02902-0. Epub 20230410.","journal-title":"Cancer Cell Int"},{"issue":"10088","key":"711_CR128","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/s0140-6736(17)31046-2","volume":"389","author":"AB El-Khoueiry","year":"2017","unstructured":"El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, et al. Nivolumab in patients with advanced hepatocellular carcinoma (Checkmate 040): an Open-Label, Non-Comparative, phase 1\/2 dose escalation and expansion trial. Lancet. 2017;389(10088):2492\u2013502. https:\/\/doi.org\/10.1016\/s0140-6736(17)31046-2. Epub 20170420.","journal-title":"Lancet"},{"issue":"28","key":"711_CR129","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.3748\/wjg.v17.i28.3322","volume":"17","author":"BJ Wang","year":"2011","unstructured":"Wang BJ, Bao JJ, Wang JZ, Wang Y, Jiang M, Xing MY, et al. Immunostaining of Pd-1\/Pd-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma. World J Gastroenterol. 2011;17(28):3322\u20139. https:\/\/doi.org\/10.3748\/wjg.v17.i28.3322.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"711_CR130","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s40425-019-0808-5","volume":"7","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhou Y, Chen C, Fang W, Cai X, Zhang X, et al. Hepatitis B virus reactivation in cancer patients with positive hepatitis B surface antigen undergoing Pd-1 Inhibition. J Immunother Cancer. 2019;7(1):322. https:\/\/doi.org\/10.1186\/s40425-019-0808-5. Epub 20191121.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"711_CR131","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1186\/s12885-025-14776-8","volume":"25","author":"L Wang","year":"2025","unstructured":"Wang L, Yang F, Dong Q, Tung TH, Ye J, Cen K, et al. Anti-Pd-1 therapy achieves favorable outcome in gastric cancer combined with chronic hepatitis B. BMC Cancer. 2025;25(1):1354. https:\/\/doi.org\/10.1186\/s12885-025-14776-8. Epub 20250822.","journal-title":"BMC Cancer"},{"key":"711_CR132","doi-asserted-by":"publisher","unstructured":"Kar A, Mukherjee S, Mukherjee S, Biswas A, Ubiquitin. A Double-Edged Sword in Hepatitis B Virus-Induced Hepatocellular Carcinoma. Virology 2024; 599:110199. Epub 20240807. https:\/\/doi.org\/10.1016\/j.virol.2024.110199","DOI":"10.1016\/j.virol.2024.110199"},{"issue":"2","key":"711_CR133","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/fsn3.70011","volume":"13","author":"S Ibrahim","year":"2025","unstructured":"Ibrahim S, Umer Khan M, Khurram I, Rehman R, Rauf A, Ahmad Z, et al. Navigating protacs in cancer therapy: Advancements, Challenges, and future horizons. Food Sci Nutr. 2025;13(2):e70011. https:\/\/doi.org\/10.1002\/fsn3.70011. Epub 20250201.","journal-title":"Food Sci Nutr"},{"issue":"5","key":"711_CR134","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1111\/cas.15733","volume":"114","author":"JJ Chen","year":"2023","unstructured":"Chen JJ, Jin JM, Gu WJ, Zhao Z, Yuan H, Zhou YD, et al. Crizotinib-Based proteolysis targeting chimera suppresses gastric cancer by promoting Met degradation. Cancer Sci. 2023;114(5):1958\u201371. https:\/\/doi.org\/10.1111\/cas.15733. Epub 20230207.","journal-title":"Cancer Sci"},{"key":"711_CR135","doi-asserted-by":"publisher","first-page":"1467449","DOI":"10.3389\/fgeed.2024.1467449","volume":"6","author":"ZQ Yao","year":"2024","unstructured":"Yao ZQ, Schank MB, Zhao J, El Gazzar M, Wang L, Zhang Y, et al. The potential of Hbv cure: an overview of Crispr-Mediated Hbv gene disruption. Front Genome Ed. 2024;6:1467449. https:\/\/doi.org\/10.3389\/fgeed.2024.1467449. Epub 20241009.","journal-title":"Front Genome Ed"},{"key":"711_CR136","doi-asserted-by":"publisher","unstructured":"Yang YC, Chen YH, Kao JH, Ching C, Liu IJ, Wang CC et al. Permanent Inactivation of Hbv Genomes by Crispr\/Cas9-Mediated Non-Cleavage Base Editing. Mol Ther Nucleic Acids 2020;20:480\u2009\u2013\u200990. Epub 20200319. https:\/\/doi.org\/10.1016\/j.omtn.2020.03.005","DOI":"10.1016\/j.omtn.2020.03.005"},{"issue":"14","key":"711_CR137","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1038\/s41388-022-02177-1","volume":"41","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Zhang X, Jiang CQ, Zhang YG, Wu X, Li J, et al. Identifying novel therapeutic targets in gastric cancer using Genome-Wide Crispr-Cas9 screening. Oncogene. 2022;41(14):2069\u201378. https:\/\/doi.org\/10.1038\/s41388-022-02177-1. Epub 20220217.","journal-title":"Oncogene"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00711-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-025-00711-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00711-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T01:04:07Z","timestamp":1763168647000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-025-00711-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1186\/s13027-025-00711-w","relation":{},"ISSN":["1750-9378"],"issn-type":[{"type":"electronic","value":"1750-9378"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}